(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Halozyme Therapeutics is 767810
Date | Daily Closing Price | Open | High | Low | Volume |
02 Thu May 2024 | 39.82 | 39.56 | 40.74 | 38.88 | 1.084 times |
01 Wed May 2024 | 39.30 | 38.40 | 40.00 | 38.30 | 1.344 times |
30 Tue Apr 2024 | 38.10 | 38.54 | 39.03 | 37.97 | 1.201 times |
29 Mon Apr 2024 | 38.77 | 38.76 | 39.39 | 38.56 | 0.949 times |
26 Fri Apr 2024 | 38.57 | 38.46 | 39.02 | 38.46 | 0.713 times |
25 Thu Apr 2024 | 38.46 | 38.71 | 38.75 | 38.23 | 0.903 times |
24 Wed Apr 2024 | 39.12 | 38.98 | 39.70 | 38.82 | 0.808 times |
23 Tue Apr 2024 | 38.97 | 38.75 | 39.42 | 38.70 | 0.727 times |
22 Mon Apr 2024 | 38.71 | 38.82 | 39.05 | 38.28 | 0.684 times |
19 Fri Apr 2024 | 38.64 | 37.73 | 38.69 | 37.73 | 1.639 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 39.8, but if it comes below 39.8, then a intra day sell could be more profitable.
If you take a sell trade below 39.8, then use 39.8 as stoploss and 38.99 as target. However if you take a buy trade in stock , then use 39.8 as stoploss and 40.7 as target.
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 33.15 |
Downside Target | 37.73 |
Downside Target | 39.69 |
Downside Target | 39.70 |
Upside Target | 40.74 |
Upside Target | 40.95 |
Upside Target | 41.36 |
Upside Target | 41.60 |
Upside Target | 42.64 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 38.28 |
Downside Intraday Target | 36.74 |
Upside Intraday Target | 41.05 |
Upside Intraday Target | 42.28 |
Downside Intraday Target | 39.51 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
02 Thu May 2024 | 39.82 | 38.76 | 40.74 | 37.97 | 1.194 times |
26 Fri Apr 2024 | 38.57 | 38.82 | 39.70 | 38.23 | 0.689 times |
19 Fri Apr 2024 | 38.64 | 38.89 | 39.27 | 37.73 | 0.809 times |
12 Fri Apr 2024 | 38.61 | 41.09 | 41.36 | 38.53 | 1.097 times |
05 Fri Apr 2024 | 41.07 | 40.68 | 41.60 | 39.44 | 1.846 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
02 Thu May 2024 | 39.82 | 38.40 | 40.74 | 38.30 | 0.098 times |
30 Tue Apr 2024 | 38.10 | 40.68 | 41.60 | 37.73 | 0.992 times |
28 Thu Mar 2024 | 40.68 | 40.00 | 42.64 | 39.69 | 0.782 times |
29 Thu Feb 2024 | 39.81 | 33.88 | 40.95 | 33.15 | 0.609 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Halozyme Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 38.85 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Halozyme Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 38.85 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.